Immunoprecise Antibodies LtdKapitalflussrechnung
| Preis (2025-09-03) | 52W Hoch | 52W Tief |
| 2.07 USD | 3,246 USD | 1,52 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 4 USD | 0 | 2 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 46.154.100 | 0,95 | 0,31 |
Kennzahl in 1000 CAD | TTM 2025-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 | 2016-04-30 | 2015-04-30 | 2002-04-30 | 2001-04-30 | 2000-04-30 | 1999-04-30 | 1998-04-30 | 1997-04-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow aus operativer Geschäftstätigkeit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
▸ Operative Cashflow Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Investitionsausgaben (CapEx) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow aus Investitionstätigkeit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow aus Finanzierungstätigkeit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Freier Cashflow | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
▸ Freie Cashflow Marge | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% | -% |
Ausgeschüttete Dividenden | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |